6th Apr 2023 21:11
Emis Group PLC - Leeds-based healthcare software producer - Announces that it, alongside Bordeaux UK Holdings II Ltd, intends to proceed with a phase two investigation by the UK Competition & Markets Authority. This follows the UK CMA's rejection of Emis' proposed remedy to address competition concerns following a phase one investigation. Says it will engage "constructively and collaboratively" with the CMA during the phase two process. Consequently, Emis and Bordeaux UK agree to extend the long stop date for completion of Emis' acquisition to June 30, 2024. Read More
